Simultaneous administration of pancuronium and alcuronium was used in surgical patients during nitrous oxide -narcotic -barbiturate anaesthesia in order to determine the intensity of neuromuscular blockade. When compared with the results obtained when each of the drugs was given alone, the effect was not greater than the additive. The mean effective dose of pancuronium to produce 95% paralysis was 76 JAg per kgfor the mechanical twitch response and 70 JAg per kgfor the electrical response. The respective mean doses of alcuronium producing that degree of paralysis were 285 and 244 /Ag per kg. Usually the curve derived for the mechanical twitch response was to the right of, and roughly parallel to, that for the electrical response.
effects are sufficiently dissimilar 6 to suggest their use in combination. This study constructs dose-response curves for the neuromuscular blocking effects of alcuronium and pancuronium both in combination and alone. METHODS Forty-eight adult patients were studied during their elective surgery, either for vascular work in the lower limb or for herniorrhaphy. Following an intramuscular narcotic premedication, anaesthesia was induced with droperidol 5-10 mg, thiopentone 100-400 mg and a narcotic, either phenoperidine or fentanyl. Endotracheal intubation was facilitated by the application of topical lignocaine. Ventilation with 70070 nitrous oxide in oxygen was adjusted to keep the end-tidal carbon dioxide in the range 4.5 to 5070. Further increments of thiopentone and narcotic were added as required.
The patients were divided into three groups of 16, depending on the neuromuscular blocking agents administered. A constant-rate infusion was set to deliver at a rate of 1 nerve at the elbow every 10 seconds. A linear force transducer was applied at right angles to the thumb of the immobilised arm with a preload of some 200 g. Silver/silver choride surface electrodes were applied across the first dorsal interspace of the hand and the evoked electromyogram (EMG) stored in digital form for subsequent display to a chart recorder. In some cases the signal was also rectified and integrated for recording on a separate channel. The gating of this signal was timed to make identical the opening and closing voltages. The depression amplitude of the compound EMG and of the height of the mechanical twitch response were compared with control values in the calculation of the intensities of paralysis.
Using not less than 20 points for each patient, dose response curves were constructed with the equation
Per cent paralysis =
The dose, D, was obtained from the timebase of the chart. With the power function, s, and the mean effective dose for 50% paralysis, K, as unknowns the dose-response data were fitted to the equation using a non-linear leastsquares regression analysis programme on an Apple 11 Plus microcomputer. The two curves derived for each patient were then used to derive values for each fifth percentile and the pooled results used to obtain composite values for the range between 5 and 95 per cent paralysis.
The pooled values for the alcuronium group and for the pancuronium group were halved, then summed to predict the positions of the curve for the mixed agents.
RESULTS
The constant-rate infusion of relaxant resulted in a progressive reduction in the evoked responses (Figure 1) . When the individual's dose-response points were plotted together with the computer-derived curve, visually they were in good agreement. In all cases the coefficient of the determination (r2) exceeded 0.98. The dose-response curve derived from the amplitude of the EMG was usually to the left of that obtained from the height of the mechanical twitch response. Although the slopes of these two curves were usually about the same, but, as can be seen from the values for S in Table 1 , in some cases they differed considerably. The curve of the integrated EMG tended to resemble that of the mechanical response. The mean of the pancuronium doses producing 50 per cent paralysis shown in Table  1 is 46 /lg/kg (SD 13) for the mechanical response and 42 /lg/kg (SD 12) for the EMG. Those for alcuronium were 159 /lg/kg (SD 42) and 137 /lg/kg (SD 33) respectively. Halved, these would predict that a mixture of the two producing 50 per cent paralysis would contain pancuronium, 23 /lg/kg and alcuronium, 80 /lg/kg, for the mechanical response. The mixture predicted for the electrical response would be pancuronium, 21 /lg/kg and alcuronium, 69 /lg/kg. These values are in good agreement with those derived for the composite curves, as shown in Table 2 and Figure 2 . The dose of pancuronium producing 95 per cent paralysis is 76 /lg/kg (SD 23) for the mechanical response and 70 J1g/kg (SD 23) for the EMG. For alcuronium these are 285 J1g/kg (SD 71) and 244 /lg/kg (SD 53) respectively. Calculation of dosage on a weight or surface area basis gave a lower percentage co-efficients of variance than that based on the total mass of drug administered.
DISCUSSION
Based on national sales, the two most popular nondepolarising neuromuscular blockers are alcuronium and pancuronium, so their use in combination is a natural consequence. Indeed, a blending of one ampoule of pancuronium (4 mg) with two of alcuronium (20 mg) has been called colloquially "the blackbird mixture". For equal slices of pie, however, Table 2 would suggest that an equipotent neuromuscular blocking ratio would be closer to 1 :4. In previous studies with different assessments of paralysis, this ratio is closer to 1: 3. 7 ,8 Combination of nondepolarising relaxants studies in the rat resulted in a dose-additive or over-additive response. 9 Increasing dosage of the second substance did not lead to a lengthening of the duration of action. Although this study tested the combination of alcuronium and pancuronium, it did so in doses which produced 100070 blockade and could not assess potentiation of paralysis intensity. In man during halothane anaesthesia, mlxmg tubocurarine and gallamine resulted in synergism rather than simple addition. lO However, these curves were criticised for the paucity of plot points. 11 Combinations of pancuronium and metocurine or pancuronium and tubocurarine potentiated neuromuscular blockade in man;4 these studies were made in the absence of inhalation agents other than nitrous oxides and various mechanisms were postulated for this enhanced potency. Yet, as shown in Figure 2 and Table 2 , combination of the nondepolarising neuromuscular blockers is not always synergistic, as has been observed with a metocurine-tubocurarine combination. 4 In conclusion, this study shows that the blocking effects of pancuronium and alcuronium are additive ( Table 2 ). It suggests that further studies should define their optimal ratio in a mixture as that which produces the least haemodynamic change.
